Company Number: 14785450

Analysis Date: 2025-07-20 12:41 UTC

1. Risk Rating: HIGH
   Given the very limited financial resources and net liabilities position at the first year-end, this company presents a high risk from a solvency and liquidity perspective. The net current liabilities of £886 against current assets of only £1,000 indicate potential cash flow constraints. Furthermore, the company is in its first full year of trading, which inherently carries execution and operational risks.

2. Key Concerns:

• Negative net assets (£-886) and net current liabilities suggest the company is currently undercapitalized and may struggle to meet short-term obligations.
• The company employs only one person (the director) and has no audit, which limits transparency and operational scale, raising sustainability questions.
• Being newly incorporated (April 2023) with minimal financial history limits the ability to assess operational performance or market traction.

3. Positive Indicators:

• Filings are up to date with no overdue accounts or confirmation statements, indicating compliance with statutory requirements.
• The sole director and 100% shareholder is a medically qualified individual, which may imply relevant expertise and commitment to the business sector (human health activities).
• The company qualifies for micro-entity reporting, simplifying compliance and reducing administrative burdens.

4. Due Diligence Notes:

• Investigate the company’s business plan, revenue generation model, and capital injection plans to assess viability and financial sustainability.
• Review any related party transactions or initial funding arrangements, especially given the sole director’s professional background.
• Assess potential contingent liabilities or off-balance sheet commitments that could exacerbate liquidity issues.
• Obtain clarification on the absence of a profit and loss statement and underlying financial performance during the period.